Clinical trials
Observational Gallbladder Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 4 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 7 |
| Recruiting | 5 |
| Not yet recruiting | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Tecnologico de Monterrey | 2 |
| University of Calgary | 2 |
| ASST Rhodense | 1 |
| Air Force Military Medical University, China | 1 |
| Assiut University | 1 |
| Azienda Unità Sanitaria Locale della Romagna | 1 |
| Connolly Hospital Blanchardstown | 1 |
| Dr Cipto Mangunkusumo General Hospital | 1 |
| Fundacion Miguel Servet | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gallbladder Diseases | 30 |
| Pancreatic Diseases | 6 |
| Choledocholithiasis | 4 |
| Cholelithiasis | 4 |
| Cholecystitis, Acute | 3 |
| Gallstones | 3 |
| Biliary Tract Diseases | 2 |
| Cholecystitis | 2 |
| Gallbladder Neoplasms | 2 |
| Jaundice, Obstructive | 2 |
Trials
Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.